EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 147 filers reported holding EXELIXIS INC in Q1 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $5,339 | -1.1% | 225 | 0.0% | 0.00% | – |
| Q4 2023 | $5,397 | +9.8% | 225 | 0.0% | 0.00% | – |
| Q3 2023 | $4,916 | +14.4% | 225 | 0.0% | 0.00% | – |
| Q2 2023 | $4,299 | -1.6% | 225 | 0.0% | 0.00% | – |
| Q1 2023 | $4,367 | +21.0% | 225 | 0.0% | 0.00% | – |
| Q4 2022 | $3,609 | +20.3% | 225 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -96.8% | 225 | -98.1% | 0.00% | -100.0% |
| Q2 2016 | $93,000 | +93.8% | 12,000 | 0.0% | 0.00% | – |
| Q1 2016 | $48,000 | -28.4% | 12,000 | 0.0% | 0.00% | – |
| Q4 2015 | $67,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.92% |